Core Viewpoint - Despite high returns this year, several popular sector funds are facing liquidation risks due to significant redemption pressures after recovering their net asset values [1][2]. Group 1: Fund Performance and Redemption Pressure - Many top-performing funds in sectors like pharmaceuticals, military, and new consumption are experiencing large redemption pressures despite their strong performance [2][4]. - A notable innovative drug fund announced a meeting to discuss modifying its contract termination clauses to avoid liquidation, highlighting the growing divergence in sector investments amid a booming stock market [2][3]. - Several funds, including a new consumption theme fund and a military industry fund, have triggered contract termination procedures due to their net asset values falling below required thresholds [3][4]. Group 2: Specific Fund Cases - An innovative drug fund reported a year-to-date return of approximately 55%, with its net asset value rising from 0.955 yuan at the beginning of the year to around 1.4 yuan [4]. - A new consumption fund recently completed its net value recovery, achieving a net asset value of 1.17 yuan, supported by investments in companies like Pop Mart and Wei Long [4]. - The military industry index has seen a year-to-date increase of nearly 20%, yet a military-themed fund is facing liquidation despite a return of about 15% this year, indicating a puzzling situation given the recent market trends [5]. Group 3: Future Outlook and Sector Opportunities - Industry experts believe that popular sectors still hold structural opportunities despite redemption pressures, particularly in the military sector, which is expected to benefit from increased military budgets and technological advancements [6]. - The innovative drug sector is also anticipated to continue its upward trajectory due to previously suppressed valuations and recent positive developments in product profitability and overseas transactions [7].

Core Viewpoint - The military industry stocks have shown strong performance recently, with the China Securities Military Industry Index rising by 5.82% in the past week, indicating a potential recovery in the sector [1][2]. Group 1: Market Performance - Several military stocks have experienced significant gains, with ST Lihang achieving four consecutive daily limit-ups, and companies like Chengfei Integration and Tianjian Technology seeing three consecutive limit-ups [2]. - The average increase for military-themed funds was approximately 5.3%, with specific funds like the Huaxia Military Safety Fund rising by 9.22% [2]. - Over 37 out of 40 military stocks in the index saw price increases during this period, reflecting strong market interest [2]. Group 2: Fundamental Improvements - The military sector is expected to see a significant improvement in performance starting from the second quarter, with many companies likely to report better earnings [2][4]. - There is a notable recovery in military demand, with some upstream companies reporting improved order volumes both year-on-year and month-on-month [1][5]. - The military industry is positioned as one of the few sectors experiencing a positive economic cycle this year, with defensive attributes that may lead to independent market performance [3][5]. Group 3: Investment Opportunities - The military sector is currently undervalued, with a price-to-book ratio of approximately 3.12, which is relatively low compared to other technology sectors [4]. - Key areas of investment interest include low-altitude economy, military electronics, and advanced military materials, which are expected to benefit from increased orders and market demand [6][7]. - The military industry is anticipated to experience a significant increase in global defense budgets starting in 2025, further stimulating the military trade market [5][7].